US Patent 11980616 Treating liver disease by selectively eliminating senescent cells

Patent

US Patent 7851626 4,4,5,5, tetrasubstituted imidazolines

US Patent 9360471 Anti-aging agents and methods to identify them

US Patent 9527847 Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using PI3 kinase inhibitors

US Patent 9630990 Inhibition of pulmonary fibrosis with nutlin-3A and peptides

US Patent 9993472 Treatment for osteoarthritis in a joint by administering a means for inhibiting MDM2

US Patent 10010546 Treatment of ophthalmic conditions by selectively removing senescent cells from the eye

US Patent 10258618 Treating pulmonary conditions by selectively removing senescent cells from the lung using an intermittent dosing regimen

US Patent 10328058 Treating atherosclerosis by removing senescent foam cell macrophages from atherosclerotic plaques

US Patent 10328073 Use of sulfonamide inhibitors of BCL-2 and BCL-xL to treat ophthalmic disease by selectively removing senescent cells

US Patent 10413542 Methods and compositions for killing senescent cells and for treating senescence-associated diseases and disorders using an inhibitor of Akt kinase

United States Patent and Trademark Office

Theodore R. Howell

A61P 3/00

A61P 9/10